Dividends vs M&A: what’s next for Evolution Mining?

Medical disruptor trials imaging technology

Dr. Ron Weinberger, CEO of the recently listed EMVision Medical Devices, discusses the company’s ambition to bring portable scanning technology directly to patients.

Afterpay to double down in US, target travellers

Afterpay Executive Director, David Hancock, discusses the recent Senate inquiry, competition in the sector, why the US has become its priority market and ‘PLAY’ – its latest innovation targeting travellers.

Santos focused on disciplined growth, cash generation

Santos CEO Kevin Gallagher says he's focused on disciplined growth leveraging existing infrastructure and delivering a low-cost, reliable and high performance business.

The a2 Milk Company to invest for further growth

The a2 Milk Company’s Managing Director and CEO, Jayne Hrdlicka, discusses the dairy nutrition company’s recent results, its target markets, what it plans to do with its cash balance and competition from Nestle.